CLEVELAND, Ohio, January 19 /PRNewswire/ -- Simbionix, the world's
leading developer of medical simulation systems, introduces its new module
for the ANGIO Mentor simulator, the Percutaneous Aortic Valve Replacement
Module, which provides physicians with an opportunity to practice a
revolutionary endovascular implantation of a bioprosthesis, without
performing cardiac surgery.
Percutaneous aortic valve replacement is an innovative minimally invasive technique for heart valve implantation. This procedure, which takes place in a catheterization lab, is performed on a beating heart, so that there is no need for a cardiopulmonary bypass and its associated risks. In addition to having the potential to treat and heal many of the patients who are ineligible for traditional open-heart surgery, including elderly patients or patients suffering from additional conditions, this new technique is also less traumatic to the patient, and reduces healthcare costs and rehabilitation time.
The new training module provides surgeons with the opportunity to practice correct placement of the bioprosthesis during an Aortic Valve Replacement, which is critical for the success of the procedure. Surgeons can train on different virtual patients, and gain experience with complicated anatomies and various pathologies. At the end of the session the surgeon can assess and analyze the deployment process and learn how to work more safely with a bioprosthesis.
Mr. Gary Zamler, Simbionix CEO adds: "The medical device field is rapidly developing, with new technologies continuously being introduced to the market and new techniques being used every day. Based on the work of our exceptionally strong R&D team, we are able to assist clinicians in keeping up with these changes, while at the same time contributing to enhanced patient safety. Device manufactures share the same needs, and require advanced and efficient training tools. Simbionix solutions provide a wide scope of opportunities to attend to this positive trend in medical device developments, an example of which is demonstrated in this new application for percutaneous aortic valve replacement".
About Simbionix USA Corporation
Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical perfomrmance and optimizing procedural outcomes. Simbionix cooperates with physicians on a regular basis to produce the most reliable and effective training and supporting systems.
Advertisement
Percutaneous aortic valve replacement is an innovative minimally invasive technique for heart valve implantation. This procedure, which takes place in a catheterization lab, is performed on a beating heart, so that there is no need for a cardiopulmonary bypass and its associated risks. In addition to having the potential to treat and heal many of the patients who are ineligible for traditional open-heart surgery, including elderly patients or patients suffering from additional conditions, this new technique is also less traumatic to the patient, and reduces healthcare costs and rehabilitation time.
Advertisement
The new training module provides surgeons with the opportunity to practice correct placement of the bioprosthesis during an Aortic Valve Replacement, which is critical for the success of the procedure. Surgeons can train on different virtual patients, and gain experience with complicated anatomies and various pathologies. At the end of the session the surgeon can assess and analyze the deployment process and learn how to work more safely with a bioprosthesis.
Mr. Gary Zamler, Simbionix CEO adds: "The medical device field is rapidly developing, with new technologies continuously being introduced to the market and new techniques being used every day. Based on the work of our exceptionally strong R&D team, we are able to assist clinicians in keeping up with these changes, while at the same time contributing to enhanced patient safety. Device manufactures share the same needs, and require advanced and efficient training tools. Simbionix solutions provide a wide scope of opportunities to attend to this positive trend in medical device developments, an example of which is demonstrated in this new application for percutaneous aortic valve replacement".
About Simbionix USA Corporation
Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical perfomrmance and optimizing procedural outcomes. Simbionix cooperates with physicians on a regular basis to produce the most reliable and effective training and supporting systems.
For more information on Simbionix, visit http://www.simbionix.com
Rebecca Zitter
Exhibition Manager
Simbionix
Tel : +1-216-229-2040
[email protected]
SOURCE Simbionix Ltd.